The DOI matches its Crossref record; 302 of the 302 references it cites were found in a registry or an index.
Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder
Open accessAbstract
Parkinson's disease (PD) is the second most common movement disorder. The characteristic motor impairments - bradykinesia, rigidity, and resting tremor - result from degenerative loss of midbrain dopamine (DA) neurons in the substantia nigra, and are responsive to symptomatic treatment with dopaminergic medications and functional neurosurgery. PD is also the second most common neurodegenerative disorder. Viewed from this perspective, PD is a disorder of multiple functional systems, not simply the motor system, and of multiple neurotransmitter systems, not merely that of DA. The characteristic pathology - intraneuronal Lewy body inclusions and reduced numbers of surviving neurons - is similar in each of the targeted neuron groups, suggesting a common neurodegenerative process. Pathological and experimental studies indicate that oxidative stress, proteolytic stress, and inflammation figure prominently in the pathogenesis of PD. Yet, whether any of these mechanisms plays a causal role in human PD is unknown, because to date we have no proven neuroprotective therapies that slow or reverse disease progression in patients with PD. We are beginning to understand the pathophysiology of motor dysfunction in PD, but its etiopathogenesis as a neurodegenerative disorder remains poorly understood.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–302 of 302
The role of primate putamen neurons in the association of sensory stimuli with movement
Kimura, M. (1986) · Neuroscience Research · doi:10.1016/0168-0102(86)90035-0 · Cited by 142
Selective Agenesis of Mesencephalic Dopaminergic Neurons in Nurr1-Deficient Mice
Le, W., Conneely, O. M., Zou, L., He, Y., Cárdenas, O. S., Jankovic, J. J., Mosier, D. R., & Appel, S. H. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7191 · Cited by 141
Shink, É., Sidib�, M., & Smith, Y. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970609)382:3<348::aid-cne4>3.0.co;2-3 · Cited by 141
Compartmental origins of the striatopallidal projection in the primate
Giménez‐Amaya, J. M., & Graybiel, A. M. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90306-o · Cited by 141
Output architecture of the primate putamen
Flaherty, A. W., & Graybiel, A. M. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-08-03222.1993 · Cited by 138
Organization of Corticostriatal Motor Inputs in Monkey Putamen
Nambu, A., Kaneda, K., Tokuno, H., & Takada, M. (2002) · Journal of Neurophysiology · doi:10.1152/jn.2002.88.4.1830 · Cited by 138
Yamada, H., Matsumoto, N., & Kimura, M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0068-04.2004 · Cited by 137
Matsumura, M., Nambu, A., Yamaji, Y., Watanabe, K., Imai, H., Inase, M., Tokuno, H., & Takada, M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00099-3 · Cited by 136
Ribeiro, M. J., Vidailhet, M., Loc’h, C., Dupel, C. P., Nguyen, J. P., Ponchant, M., Dollé, F., Peschanski, M., Hantraye, P., Césaro, P., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.4.580 · Cited by 134
Deep brain stimulation of the pedunculopontine region in the normal non-human primate
Nandi, D., Liu, X., Winter, J. L., Aziz, T. Z., & Stein, J. F. (2002) · Journal of Clinical Neuroscience · doi:10.1054/jocn.2001.0943 · Cited by 133
Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8-year follow-up
ONOFRJ, M. C., Thomas, A., D’Andreamatteo, G., Iacono, D., Luciano, A. L., Rollo, A. D., Mascio, R. D., Ballone, E., & Iorio, A. D. (2002) · Neurological Sciences · doi:10.1007/s100720200085 · Cited by 131
Ali, S. F., David, S. N., Newport, G. D., Cadet, J. L., & Slikker, W. (1994) · Synapse · doi:10.1002/syn.890180105 · Cited by 131
Topographic intermingling of striatonigral and striatopallidal neurons in the rhesus monkey
Selemon, L. D., & Goldman-Rakic, P. S. (1990) · The Journal of Comparative Neurology · doi:10.1002/cne.902970304 · Cited by 131
Swallowing and esophageal function in Parkinson's disease.
Johnston, B. T., Li, Q., Castell, J. A., & Do, C. (1995) · PubMed · Cited by 130
Distribution of DARPP-32 in the basal ganglia: an electron microscopic study
Ouimet, C. C., & Greengard, P. (1990) · Journal of Neurocytology · doi:10.1007/bf01188438 · Cited by 127
Pathophysiologic basis of surgery for Parkinson's disease.
Obeso, J. A., Rodríguez-Oroz, M. C., Rodriguez, M., Macıás, R., Álvarez, L., Guridi, J., Vitek, J. L., & DeLong, M. R. (2000) · PubMed · Cited by 126
No evidence for heritability of Parkinson disease in Swedish twins
Wirdefeldt, K., Gatz, M., Schalling, M., & Pedersen, N. L. (2004) · Neurology · doi:10.1212/01.wnl.0000129841.30587.9d · Cited by 124
Visuospatial dysfunction and problem solving in Parkinson's disease.
Cronin‐Golomb, A., & Braun, A. E. (1997) · Neuropsychology · doi:10.1037//0894-4105.11.1.44 · Cited by 123
Free radicals in Parkinson's disease
Koutsilieri, E., Scheller, C., Grünblatt, E., Keinosuke, N. A. R. A., Li, J., & Riederer, P. F. (2002) · Journal of Neurology · doi:10.1007/s00415-002-1201-7 · Cited by 123
Presynaptic μ and δ Opioid Receptor Modulation of GABAAIPSCs in the Rat Globus PallidusIn Vitro
Stanford, I. M., & Cooper, A. J. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-12-04796.1999 · Cited by 122
Jenner, P. G. (2003) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(02)00115-3 · Cited by 119
Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson’s disease
Xu, P., Liang, R., Jankovic, J. J., Hunter, C., Zeng, Y.-X., Ashizawa, T., Lai, D., & Le, W. (2002) · Neurology · doi:10.1212/wnl.58.6.881 · Cited by 118
Altered systemic iron metabolism in Parkinson's disease
Logroscino, G., Marder, K. S., Graziano, J. H., Freyer, G. A., Slavkovich, V. N., LoIacono, N. J., Cote, L. J., & Mayeux, R. P. (1997) · Neurology · doi:10.1212/wnl.49.3.714 · Cited by 118
Activation of basal ganglia loops in idiopathic Parkinson?s disease: a PET study
Thiel, A., Hilker, R., Kessler, J., Habedank, B., Herholz, K., & Heiss, W. ‐. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0041-7 · Cited by 118
Dopaminergic modulation of visual sensitivity in man
Masson, G. S., Mestre, D., & Blin, O. (1993) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1993.tb01041.x · Cited by 118
Faucheux, B. A., Martin, M., Beaumont, C., Hunot, S., Hauw, J., Agid, Y., & Hirsch, E. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01118.x · Cited by 116 · cited 1×
“155,156 Iron is chemically inactive when bound to ferritin as Fe 3+ , whereas unbound iron in the ferrous state (Fe 2+ ) can combine with H 2 O 2 in the Fenton reaction to produce the reactive hydroxyl radical (OH • ).”
Amini, B., Clark, J. W., & Canavier, C. C. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.5.2249 · Cited by 116
Midbrain dopaminergic neurons: determination of their developmental fate by transcription factors.
Simon, H. H., Bhatt, L., Gherbassi, D., Sgadó, P., & Alberi, L. A. (2003) · PubMed · Cited by 114
Neurodegeneration or Neuroprotection: The Pivotal Role of Astrocytes
Heales, S., Lam, A., Duncan, A. J., & Land, J. M. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000014822.69384.0f · Cited by 114
Sidibé, M., Paré, J., & Smith, Y. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10247 · Cited by 113
Alcantara, A. A., Mrzljak, L., Jakab, R. L., Levey, A. I., Hersch, S. M., & Goldman‐Rakic, P. S. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1186 · Cited by 113
Hughes, S. W., Cope, D. W., Toth, T. I., Williams, S. R., & Crunelli, V. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.0805s.x · Cited by 111
The striatopallidal projection displays a high degree of anatomical specificity in the primate
Hazrati, L., & Parent, A. (1992) · Brain Research · doi:10.1016/0006-8993(92)91679-9 · Cited by 108
Deep Brain Stimulation and Thalamotomy for Tremor Compared
Tasker, R. R., Munz, M., Junn, F., Kiss, Z. H. T., Davis, K. D., Dostrovsky, J. O., & Lozano, A. M. (1997) · Acta neurochirurgica. Supplementum · doi:10.1007/978-3-7091-6513-3_9 · Cited by 107
Takakusaki, K., Saitoh, K., Harada, H., Okumura, T., & Sakamoto, T. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.10.028 · Cited by 104
Thalamic, subthalamic nucleus and internal pallidum stimulation in Parkinson's disease
Limousin, P. D., Pollak, P., Blercom, N. V., Krack, P., Benazzouz, A., & Benabid, A. (1999) · Journal of Neurology · doi:10.1007/bf03161080 · Cited by 104
Cheng, K., Saleem, K. S., & Tanaka, K. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-20-07902.1997 · Cited by 102
Influence of neuromelanin on oxidative pathways within the human substantia nigra
Double, K. L., Ben-Shachar, D., Youdim, M. B. H., Zecca, L., Riederer, P., & Gerlach, M. (2002) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(02)00218-0 · Cited by 102
Neuroprotection in Parkinson's disease: Clinical trials
Stocchi, F., & Olanow, C. W. (2003) · Annals of Neurology · doi:10.1002/ana.10488 · Cited by 102
Functional imaging in Parkinson's disease: activation studies with PET, fMRI and SPECT
Ceballos-Baumann, A. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1103-1 · Cited by 101
Bevan, M. D., Wilson, C. J., Bolam, J. P., & Magill, P. J. (2000) · Journal of Neurophysiology · doi:10.1152/jn.2000.83.5.3169 · Cited by 100
A Common NURR1 Polymorphism Associated With Parkinson Disease and Diffuse Lewy Body Disease
Zheng, K., Heydari, B., & Simon, D. K. (2003) · Archives of Neurology · doi:10.1001/archneur.60.5.722 · Cited by 100
Dopamine and cognitive function
Pillon, B., Czernecki, V., & Dubois, B. (2003) · Current Opinion in Neurology · doi:10.1097/00019052-200312002-00004 · Cited by 98
Qualitative and quantitative analysis of locus coeruleus neurons in Parkinson's disease.
Bertrand, E., Lechowicz, W., Szpak, G. M., & Dymecki, J. (1997) · PubMed · Cited by 95
Dynorphin Exerts Both Postsynaptic and Presynaptic Effects in the Globus Pallidus of the Rat
Ogura, M., & Kita, H. (2000) · Journal of Neurophysiology · doi:10.1152/jn.2000.83.6.3366 · Cited by 94
Inase, M., Sakai, S. T., & Tanji, J. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960916)373:2<283::aid-cne10>3.0.co;2-m · Cited by 93
Takada, M., Tokuno, H., Nambu, A., & Inase, M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00198-x · Cited by 92
Liu, X., Ford-Dunn, H. L., Hayward, G., Nandi, D., Miall, R. C., Aziz, T. Z., & Stein, J. F. (2002) · Clinical Neurophysiology · doi:10.1016/s1388-2457(02)00256-0 · Cited by 92
Dementia and Parkinson's Disease
Gibb, W. R. G. (1989) · The British Journal of Psychiatry · doi:10.1192/bjp.154.5.596 · Cited by 91
Simon, H. H., Bhatt, L., Gherbassi, D., Sgadó, P., & Alberi, L. A. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07461.x · Cited by 91
Fessel, J. P., Hulette, C., Powell, S. Z.-E., Roberts, L. J., & Zhang, J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01709.x · Cited by 90
Autonomic dysfunction in movement disorders
Chaudhuri, К. R. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00012 · Cited by 88
Role of dorsal raphe nucleus serotonin 5-HT1A receptor in the regulation of REM sleep
Monti, J. M., & Monti, D. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00649-9 · Cited by 84
Mortality and Parkinson disease: A community based study
Herlofson, K., Lie, S. A., Årsland, D., & Larsen, J. O. (2004) · Neurology · doi:10.1212/01.wnl.0000115116.56955.50 · Cited by 84
Parkinson's disease: changes in apoptosis-related factors suggesting possible gene therapy
Nagatsu, T. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200061 · Cited by 83
The intermediolateral nucleus and Clarke's column in Parkinson's disease
Wakabayashi, K., & Takahashi, H. (1997) · Acta Neuropathologica · doi:10.1007/s004010050705 · Cited by 82
Kimura, M., Aosaki, T., Hu, Y., Ishida, A., & Watanabe, K. (1992) · Experimental Brain Research · doi:10.1007/bf00229870 · Cited by 81
Treatment of advanced Parkinson's disease by subthalamotomy: One‐year results
Su, P., Tseng, H.-M., Liu, H.-M., Yen, R., & Liou, H. (2003) · Movement Disorders · doi:10.1002/mds.10393 · Cited by 75
Sleep dysfunction in Parkinson's disease.
Trenkwalder, C. (1998) · PubMed · Cited by 75
Ilinsky, I. A., Yi, H. L., & Kultas‐Ilinsky, K. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19971006)386:4<601::aid-cne6>3.0.co;2-6 · Cited by 74
Purba, J. S., Hofman, M. A., & Swaab, D. F. (1994) · Neurology · doi:10.1212/wnl.44.1.84 · Cited by 73
Kultas‐Ilinsky, K., & Ilinsky, I. A. (1990) · The Journal of Comparative Neurology · doi:10.1002/cne.902940314 · Cited by 73
Pharyngeal and Upper Esophageal Sphincter Manometry in the Evaluation of Dysphagia
Hila, A., Castell, J. A., & Castell, D. O. (2001) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200111000-00003 · Cited by 72 · cited 1×
“Postganglionic parasympathetic cell loss and LB pathology within upper portions of the myenteric plexus account for the esophageal and gastric dysmotility syndromes that are common accompaniments of PD(87); esophageal involvement, when severe, can be indistinguishable from achalasia.(90) Involvement of the Biology of…”
Motor imagery in normal subjects and Parkinson's disease patients: an H215O PET study
Samuel, M., Ceballos-Baumann, A., Boecker, H., & Brooks, D. J. (2001) · Neuroreport · doi:10.1097/00001756-200103260-00040 · Cited by 68
Abnormal gaze strategies during problem solving in Parkinson's disease
Hodgson, T. L., Tiesman, B., Owen, A. M., & Kennard, C. (2002) · Neuropsychologia · doi:10.1016/s0028-3932(01)00099-9 · Cited by 67
Sakai, S. T., Inase, M., & Tanji, J. (1999) · Anatomy and Embryology · doi:10.1007/s004290050204 · Cited by 66
Neuropathology of the Substantia nigra
Gibb, W. R. G. (2008) · European Neurology · doi:10.1159/000116721 · Cited by 66
Kostrzewa, R. M., Kostrzewa, J. P., & Brus, R. (2002) · Amino Acids · doi:10.1007/s00726-001-0110-x · Cited by 64
α-Synuclein: Its Biological Function and Role in Neurodegenerative Diseases
Kaplan, B., Ratner, V., & Haas, E. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:2:83 · Cited by 64
Association Study of Parkin Gene Polymorphisms With Idiopathic Parkinson Disease
Oliveira, S. A., Scott, W. K., Nance, M., Watts, R. L., Hubble, J. P., Koller, W. C., Lyons, K. E., Pahwa, R., Stern, M. B., Hiner, B. C., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.7.975 · Cited by 62
Wong, A. C., Shetreat, M. E., Clarke, J. O., & Rayport, S. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00284-x · Cited by 62
Haug, B. A., Trenkwalder, C., Arden, G. B., Oertel, W. H., & Paulus, W. (1994) · Movement Disorders · doi:10.1002/mds.870090510 · Cited by 60
FADD: A link between TNF family receptors and caspases in Parkinson’s disease
Hartmann, A., Prigent, A., Faucheux, B. A., Agid, Y., & Hirsch, É. C. (2002) · Neurology · doi:10.1212/wnl.58.2.308 · Cited by 60
Ilinsky, I. A., & Kultas‐Ilinsky, K. (1990) · The Journal of Comparative Neurology · doi:10.1002/cne.902940313 · Cited by 60
Peppe, A., Stanzione, P., Pierantozzi, M., Semprini, R., Bassi, A., Santilli, A. M., Formisano, R., Piccolino, M., & Bernardi, G. (1998) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/s0013-4694(97)00075-8 · Cited by 59
Gao, D. M., Benazzouz, A., Piallat, B., Bressand, K., Ilinsky, I. A., Kultas‐Ilinsky, K., & Benabid, A. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00235-8 · Cited by 55
Functional Neuropathology in Parkinson's Disease
Gibb, W. R. G. (2008) · European Neurology · doi:10.1159/000113472 · Cited by 54
Organization of midbrain dopamine systems and the pathophysiology of Parkinson's disease
Moore, R. Y. (2003) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(03)00063-4 · Cited by 52
Subthalamic Prelemniscal Radiation Stimulation for the Treatment of Parkinson's Disease
Jiménez, F., Velasco, F., Velasco, M., Brito, F., Morel, C., Márquez, I., & Pérez, M. L. (2000) · Archives of Medical Research · doi:10.1016/s0188-4409(00)00066-7 · Cited by 50
Eells, J. B. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457700 · Cited by 50
Kaneda, K., Nambu, A., Tokuno, H., & Takada, M. (2002) · Journal of Neurophysiology · doi:10.1152/jn.2002.88.3.1420 · Cited by 45
NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits
Carmine, A., Buervenich, S., Galter, D., Jönsson, E. G., Sedvall, G. C., Farde, L., Gustavsson, P. J., Bergman, H., Chowdari, K. V., Nimgaonkar, V. L., et al. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20033 · Cited by 44
Jahanshahi, M., Rowe, J. B., Saleem, T., Brown, R. G., Limousin, P. D., Rothwell, J. C., Thomas, D. G. T., & Quinn, N. P. (2002) · Journal of Cognitive Neuroscience · doi:10.1162/089892902317236911 · Cited by 44
Visual Electrophysiology in Parkinson's Disease: PERG, VEP and Visual P300
Bodis-Wollner, I. G. (1997) · Clinical Electroencephalography · doi:10.1177/155005949702800305 · Cited by 43
Novel mitochondrial DNA mutations in Parkinson's disease
Richter, G., Sonnenschein, A., Grünewald, T. G. P., Reichmann, H., & Janetzky, B. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200060 · Cited by 42
Glial Cell Response: A Pathogenic Factor in Parkinson's Disease
Wu, D. C., Tieu, K., Cohen, O. S., Choi, D., Vila, M., Jackson-Lewis, V. R., Teismann, P., & Przedborski, S. (2002) · Journal of NeuroVirology · doi:10.1080/13550280290100905 · Cited by 41
Hemiballism after subthalamotomy in patients with Parkinson's disease: Report of 2 cases
Chen, C., Lee, S., Wu, T., Chen, C., Huang, C., & Lu, C. (2002) · Movement Disorders · doi:10.1002/mds.10286 · Cited by 40
Simultaneous VEP and PERG investigations in early Parkinson's disease.
Calzetti, S., Franchi, A., Taratufolo, G., & Groppi, E. (1990) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.53.2.114 · Cited by 37
Potential neurotoxic “agents provocateurs” in Parkinson's disease
Collins, M. A., & Neafsey, E. J. (2002) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(02)00210-6 · Cited by 36
Lewy body dementia — clinical, pathological and neurochemical interconnections
Perry, R., McKeith, I. G., & Perry, E. K. (1997) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6846-2_8 · Cited by 34
A model of the Parkinsonian visual system: support for the dark adaptation hypothesis
Wink, B., & Harris, J. (2000) · Vision Research · doi:10.1016/s0042-6989(00)00036-5 · Cited by 34
Neuronal loss and plasticity in the supraoptic nucleus in Parkinson's disease
Ansorge, O., Daniel, S. E., & Pearce, R. K. B. (1997) · Neurology · doi:10.1212/wnl.49.2.610 · Cited by 34
The genetics of Parkinson’s disease
Lim, K., Dawson, V. L., & Dawson, T. M. (2002) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-002-0071-9 · Cited by 34
Yung, K. K. L., & Bolam, J. P. (2000) · Synapse · doi:10.1002/1098-2396(20001215)38:4<413::aid-syn6>3.0.co;2-v · Cited by 31
Ginsberg, S. D., Hof, P. R., Young, W. G., & Morrison, J. H. (1993) · The Journal of Comparative Neurology · doi:10.1002/cne.903270410 · Cited by 29
A spatial and quantitative study of the striatopallidal connection in the monkey
Yelnik, J., François, C., Percheron, G., & Tandé, D. (1996) · Neuroreport · doi:10.1097/00001756-199604100-00006 · Cited by 28
Effect of intention and visual fixation disengagement on prosaccades in Parkinson’s disease patients
Crevits, L., Vandierendonck, A., Stuyven, E., Verschaete, S., & Wildenbeest, J. (2003) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2003.10.005 · Cited by 22
Genetic polymorphisms of the N -acetyltransferase genes and risk of Parkinson’s disease
van der Walt, J. M., Martin, E. R., Scott, W. K., Zhang, F., Nance, M., Watts, R. L., Hubble, J. P., Haines, J. L., Koller, W. C., Lyons, K. E., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000055929.84668.9a · Cited by 18
Marco, F. D., Foppoli, C., Coccia, R., Blarzino, C., Marzia Perluigi, A., Cini, C., & Marcante, M. L. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.127 · Cited by 13
Therapeutic strategies for Parkinson's disease based on data derived from genetic research
Rieß, O., Berg, D., Krüger, R., & Schulz, J. B. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1101-3 · Cited by 6
Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3
Yeterian (1998) · doi:10.1002/(sici)1096-9861(19980928)399:3<384::aid-cne7>3.0.co;2-x
Cited by
Zielonka, J., Joseph, J., Sikora, A., Hardy, M., Ouari, O., Vasquez-Vivar, J., Cheng, G., Lopez, M., & Kalyanaraman, B. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00042 · Cited by 1,683
Maiti, P., Manna, J., & Dunbar, G. L. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0099-z · Cited by 525
Manoharan, S., Guillemin, G. J., Abiramasundari, R. S., Essa, M. M., Akbar, M., & Akbar, M. D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8590578 · Cited by 523
Picca, A., Calvani, R., Coelho-Junior, H. J., Landi, F., Bernabei, R., & Marzetti, E. (2020) · Antioxidants · doi:10.3390/antiox9080647 · Cited by 437
Role of NAD+ in regulating cellular and metabolic signaling pathways
Amjad, S., Nisar, S., Bhat, A. A., Shah, A. R., Frenneaux, M. P., Fakhro, K., Haris, M., Reddy, R., Patay, Z., Baur, J., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101195 · Cited by 384
Metadata
- Authors
- Alexander, G. E.
- Venue
- Dialogues in Clinical Neuroscience
- Publisher
- Informa UK Limited
- Published
- 2004-09-30
- Volume
- 6
- Issue
- 3
- Pages
- 259-280
- ISSN
- 1294-8322 (ISSN-L)
- 1958-5969
- OpenAlex
- W4213459747
- Cited by
- 523
- References
- 302
- FWCI
- 0.21
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.